- Physician-led orthopedic ASC opens in Florida
- $10M IU Health investment, donor gift aim to boost Indiana nursing pipeline
- Colorado Medicaid ABA audit finds $77.8M in improper payments
- Georgia opens 30-bed forensic mental health unit to ease jail backlog
- Pennsylvania county cuts ribbon on $19.8M mental health diversion center
- Outpatient cardiology’s CMS whiplash
- 12 new ASCs in February
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- Medline pilots AI supply chain platform with 10 systems
- Minnesota hospitals generate $1B+ in 340B revenue
- 1 hospital’s strategy to cut cardiovascular deaths in pregnancy, postpartum
- FDA flags critical software issue in infusion pumps
- AdventHealth taps regional chief strategy officer
- Culture is the backbone of strategy — and the key to healthcare’s future
- Cigna acquires hospital pharmacy company CarepathRx
- The ASC-payer leverage battle
- WVU Medicine hospital names interim CEO
- 15 dentists making headlines
- What’s driving clinicians to quit, stay
- CMS to suspend enrollment into Elevance’s Medicare Advantage plans
- The biggest threats to the ASC model
- U.S. Tops 1,100 Measles Cases This Year as Outbreaks Grow
- FDA To Offer Cash Bonuses for Faster Drug Reviews
- 10 providers seeking RCM talent
- Carteret Health Care breaks ground on $50M outpatient campus, ASC
- PDS Health added de novos across 3 states in February
- Novant posts 4.8% operating margin in 2025
- Texas hospitals to merge under Tenet lease agreement
- The anesthesia physician shortage by state, by 2036
- Cleveland Clinic posts $913M operating income, 5% margin — 7 things to know
- Rutgers to unveil preventive cardiology program
- New Drug, Acoziborole, Could Boost Efforts to Wipe Out Sleeping Sickness
- Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug
- Clinician Engagement: The Operating Lever Behind Margin and Throughput
- Your Anesthesia Subsidy: Key Questions Every Hospital C-Suite Must Answer
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Urban Traffic Noise Disrupts Sleep, Affects Heart Health After One Night
- Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients
- Benzodiazepine Use Down In U.S., But OD Risk Remains, Study Says
- GLP-1 Drugs Might Ease Chronic Migraine, Study Says
- Blood Test Reveals Alcohol-Related Liver Disease
- Telemedicine Visits Cost Five Times Less Than In-Clinic Care
- Medicaid Is Paying for More Dental Care. GOP Cuts Threaten To Reverse the Trend.
- Families Defend Disability Services Amid Medicaid Cuts
- Bavarian Nordic CEO to follow board chair out the door after failed private equity takeover
- Ascendis gains more altitude with FDA approval for dwarfism drug Yuviwel
- CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
- Tennr takes aim at phone call bottlenecks as it builds out automation for patient referral process
- DoseSpot, Arrive Health merge to combine prescribing tools with pharmacy, medical benefit data
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Electronics Pollution Pose Added Threat to Endangered Dolphins, Porpoises
- Flea And Tick Pills May Pose Environmental Risks, Study Finds
- ICE, ALS, Addiction Medicine, and Robotic Ultrasounds: Journalists Sound Off on All That and More
- 11 behavioral health executive moves to know
- 3 behavioral healthcare M&A deals in 2026
- New York City to invest $20M in perinatal mental health
- Anthem Blue Cross of California pushes E/M downcoding policy to April
- States shaping behavioral health parity enforcement: 7 things to know
- ‘Taking the finances off the table’: Sanford COO talks alignment with health plans
- Sarasota Memorial disputes OIG audit alleging $12.1M in Medicare overpayments
- Sending clinicians on 911 calls: What to know from this Michigan pilot
- Iowa dentist surrenders license
- Temple University gets approval for $3.19M rural dental clinic
- A Canadian Hospital Scoops Up Nurses Who No Longer Feel Safe in Trump’s America
- California weighs legislation to increase dental plan transparency: 5 things to know
- Dentsply Sirona launches restructuring plan: 8 notes
- American Academy of Pediatric Dentistry opposes EPA fluoride assessment plan: 7 notes
- Statement on the Adoption of Final Rules Under the Holding Foreign Insiders Accountable Act
- Statement on Final Rules for the Holding Foreign Insiders Accountable Act
- San Francisco OKs performance-based sobering center
- Clover Health CEO said company sees opportunity in complex MA environment
- Georgia School of Orthodontics appoints interim COO
- How pharma marketers are capturing the power of podcasts to connect with consumers
- Top 10 dental, DSO stories in February
- Aria Care Partners acquires Georgia dental provider
- Cigna's Evernorth quietly acquires hospital pharmacy CarepathRx
- Walgreens debuts virtual weight management clinic with access to GLP-1 meds
- New Obamacare Rules Could Raise Deductibles to $31K For Families
- Study Suggests One Common Amino Acid May Affect How Long Men Live
- Merck to wind down Gardasil production at N.C. plant, lay off 150-plus
- Walmart Great Value Cottage Cheese Recalled Over Pasteurization Issue
- Chris Bosh Says He’s 'Lucky To Be Alive' After Sudden Health Scare
- Patrick Kennedy: Collab with MAHA is essential to address mental health crisis
- Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
- Alignment CEO John Kao offers measured response to proposed 2027 MA rates
- Sanofi, Genentech, Kedrion back star-studded bleeding disorder awareness campaign
- Op-ed: Our patients deserve better safety reporting. AI could be the answer
- After CHMP nod, Moderna CEO applauds EU's 'rigorous scientific review'
- UCB's fast-growing Bimzelx leaps across blockbuster sales threshold as HS momentum builds
- How the Brain Learns to Have Seizures During Sleep
- Blood Test Can Predict Short-Term Survival Among Seniors
- Why Turning 19 Spikes Medicaid Loss for Millions
- Crash Course Might Speed Brain Stimulation Treatment For Depression, Study Suggests
- Wildfire Smoke Linked To Increase In Violent Assaults
- More Parents Are Refusing A Life-Saving Shot For Their Newborns, Study Finds
- To Avoid Care Disruptions, Know When the Clock Runs Out on Your Prior Authorization
- He Needs an Expensive Drug. A Copay Card Helped — Until It Didn’t.
- As SCOTUS takes on 'skinny label' review, top US lawyer sides with generics maker
- Lake Nona Impact Forum: There can't be longevity without tech
- Fierce Pharma Asia—China deal growth; Daiichi's new CMO; Astellas-Vir bispecific tie-up
- Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Smith+Nephew signs distribution agreement with SI-BONE
- Smith+Nephew signs distribution agreement with SI-BONE
- Quantum Surgical Acquires NeuWave Medical, Inc.
- Quantum Surgical Acquires NeuWave Medical, Inc.
- How Pharma is Expanding its Global Footprint to Advance Clinical Research
- Partnering to Advance Drug Delivery Innovation
- What the Health? From KFF Health News: What About the State of Health?
- Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model
- CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health
- Insurance groups say proposed flat Medicare Advantage rates fail to meet the moment
- Health Gorilla urges court to toss lawsuit filed by Epic, health systems
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Democrat-Led States Sue Trump Administration Over Cuts to Childhood Vaccine Schedule
- CDC Vaccine Advisory Panel To Revisit COVID Shot Safety Next Month
- Frozen Blueberry Recall Issued Across Four States for Listeria
- Boehringer's Hernexeos secures speedy first-line expansion in FDA's 2nd national priority nod
- 'Like talking to a brick wall': Senate hearing takes aim at FDA's rare disease review process
- After delay, CDC vaccine panel sets new dates to discuss long COVID and mRNA shot safety
- After delay, CDC vaccine panel sets new dates to discuss long COVID and mRNA shot safety
- Decision Criteria for Technology Commercialization of Medical Devices in 2026
- Decision Criteria for Technology Commercialization of Medical Devices in 2026
- Cientos de enfermeros estadounidenses dejan atrás el Estados Unidos de Trump y eligen trabajar en Canadá
- Continuous Cardiac Monitoring: Redefining the “End” of a Clinical Study?
- Continuous Cardiac Monitoring: Redefining the “End” of a Clinical Study?
- Could Drone-Delivered Defibrillators Save Lives?
- Eisai points the way to kidney cancer support with Kompass digital hub
- Sarepta CEO Doug Ingram to retire after a decade of Duchenne breakthroughs and controversies
- Inflammation Linked To Brain Damage, Memory Problems Among Football Players
- Early Birds, Active Folks Less Likely To Develop ALS
- Disasters Can Affect Mental Health A Decade Later, Review Finds
- AI Chatbots Can Contribute To Worsening Mental Illness, Study Finds
- Newborns Exposed to More ‘Forever Chemicals’ Than Once Thought
- Study Highlights Unique Parenting Struggles of Younger Patients With Heart Disease
- Altman-backed startup Verifiable rolls out AI agent to automate credentialing
- ‘You Aren’t Trapped’: Hundreds of US Nurses Choose Canada Over Trump’s America
- ‘Kind of Morbid’: Health Premiums Threaten Their Nest Egg. A Terminal Diagnosis May Spare It.
- OpenEvidence releases AI-integrated dialer feature to expand its reach with clinicians
- CMS unveils new initiatives aimed at cracking down on healthcare fraud
- After 2025's volumes shortfall, Universal Health Services says capacity, headcount investments will pay off in 2026
Interlochen Public Radio interviewed personnel from the Michigan State Police (MSP) Forensic Science Division (FSD) and Harm Reduction Michigan about the changing nature of illegal drugs being confiscated in Michigan:
https://www.michigan.gov/msp/divisions/forensic-science
Purer meth, less pure opioids, more cocaine hit Michigan, testing reveals
By Maxwell Howard of Interlochen Public Radio | February 14, 2026Mexican drug cartels are shipping purer forms of meth into rural Michigan, replacing the drugs that were once made in home labs and full of impurities, police and lab testing data shows.
Meanwhile, opioids have been cut with more impurities that can render overdose treatment ineffective and cocaine use is on the rise, the data shows.
The lab results show rural parts of the state are rife with methamphetamine, cities have more cocaine, and opioids are everywhere in lesser amounts.
While Michigan’s drug overdose deaths have fallen from a high of 3,000 in 2021 to just more than 1,900 in 2024, the most recent state data shows, drug use remains high. Some 269,000 Michiganders 12 and older reported using illicit drugs other than marijuana in 2023 and 2024, the most recent federal data shows.
Local production of meth has grinded to a halt within the last five years, said Elaine Dougherty, lab manager at the Michigan State Police Bridgeport crime lab.
“Now, we get the crystal meth from the drug cartels,” said Doughterty. “It's not made from Sudafed anymore. It's not made in pop bottles anymore. It's literally made in factories in Mexico.”
In Grayling, about 60% of the drugs tested at that crime lab are meth, while Marquette comes in over 80%. Opioids and cocaine each make up roughly 10% to 15% in those labs.
While cocaine is a smaller percentage of the drugs tested across the state, Dougherty said the drug is more popular than it’s been in years, driven in part by increased production in South and Central America.
The number of tests run for cocaine at State Police crime labs statewide has almost doubled within the last three years — from 15% to 28%. That follows global trends showing the number of global cocaine users has grown to 25 million people in 2023, up from 17 million a decade earlier, according to the United Nation’s 2025 World Health Report.
That report says an estimated 3,708 tons of cocaine were manufactured in 2023, increasing by almost 1,000 tons from the year before. The increased supply has increased access and purity of the drug for users.
Opioids, Dougherty said, are the most heavily adulterated drugs on Michigan’s market, with around 20% of synthetic fentanyl samples containing xylazine, a sedative often paired with opioids for its similar effects.
Xylazine does not act on the same opioid receptors pathway, so opioid overdose reversal medication such as Naloxone does not work.
“We were rarely seeing large amounts of xylazine in a sample,” said Doughtery. “I know on the East Coast, they were seeing samples with five times as much xylazine as fentanyl.”
Xylazine levels peaked in Michigan in early 2025, according to MSP lab data, being found in 34% of fentanyl samples. That gradually declined at the end of the year.
Another non-opioid veterinary sedative, medetomidine, has increased from being non-existent in the last year to being found in over 12% of fentanyl samples. That drug behaves much in the same way as xylazine, but is 100 times more potent.
In 2024, three overdoses in Michigan were linked to medetomidine, leading state health officials to raise the alarm.
Damage by xylazine can result in deep skin wounds by restricting blood flow and damaging tissue.
Staff at Traverse City’s Harm Reduction MI office report treating xylazine wounds occasionally — usually with groups and in small timeframes.
“If fentanyl with xylazine makes it to Traverse City, it's likely several people are ingesting it. Especially if you always get your drugs from the same source,” said Dougherty.
One reason for that risk, she said, is that local dealers often don’t know what’s in the drugs.
“The dealers don't know when their stuff has xylazine in it,” said Dougherty. “In an odd way, (dealers) take pride in what they sell. So if they are saying they're selling cocaine, they want those customers to come back. So they want it to be cocaine that they're selling.”
Harm Reduction also tests drugs across the state, but at a different entry point than the State Police. While the state labs test drugs after they are confiscated, Harm Reduction MI tests drugs while they are on the street.
Director Pamela Lynch said most people usually find the nonprofit through word of mouth and come to test their drugs after a bad reaction. Harm Reduction’s testing data often includes more minute data than the state lab, which reports drug mixtures and cocktails.
Lynch’s lab data also reports different cocktails, but also reveals smaller adulterants — substances which appear in drugs incidentally or for little known purposes.
Around two months back, Lynch said, a woman brought in a substance to be tested after her boyfriend had an especially bad reaction and had trouble communicating. The sample later came back with results of PVC plastic.
“A lot of times, people know there's a lot of stuff in there that doesn't belong in there,” said Lynch.
Common adulterants include caffeine, acetaminophen, lidocaine, antidepressants and sugars. Sometimes, the substances are unexpected.
“We even had a sample recently with flower dye,” said Lynch. “The flower dye actually ends up making little spots on their skin.”
Whether knowing what’s in illegal drugs changes behavior — for dealers or people in active addiction — is unclear. But for Lynch, the purpose of her lab is to keep people as healthy as they can until a person is ready for recovery.
“They may think that they have a safe supply. They may trust their dealer,” said Lynch. “They all know they're buying fentanyl. They don't know that they're buying xylazine until they test it.”
This reporting is made possible by the Northern Michigan Journalism Collaborative, led by Bridge Michigan and Interlochen Public Radio, and funded by Press Forward Northern Michigan.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















